_id
6915fba8bc934aba376b273e
Ticker
SNDX
Name
Syndax Pharmaceuticals Inc
Exchange
NASDAQ
Address
730 Third Avenue, New York, NY, United States, 10017
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://syndax.com
Description
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Last Close
19.98
Volume
1849265
Current Price
19.51
Change
-2.3523523523523466
Last Updated
2025-12-04T13:17:13.968Z
Image
data:image/webp;base64,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
Ipo Date
2016-03-03T00:00:00.000Z
Market Cap
1713091456
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7866666666666667
Sentiment Sources
9
Rating
4.6667
Target Price
39.3077
Strong Buy
9
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
45871000
Cost Of Revenue
6378000
Gross Profit
39493000
Operating Expenses
96919000
Operating Income
-57426000
Interest Expense
3014000
Pretax Income
-60715000
Net Income
-60715000
Eps
-0.7009270916684953
Dividends Per Share
-
Shares Outstanding
86914838
Income Tax Expense
-
EBITDA
-57700000
Operating Margin
-125.1902073205293
Total Other Income Expense Net
-3289000
Cash
116808000
Short Term Investments
337366000
Receivables
25403000
Inventories
27505000
Total Current Assets
529830000
Property Plant Equipment
1599000
Total Assets
551792000
Payables
13826000
Short Term Debt
23256000
Long Term Debt
-
Total Liabilities
436362000
Equity
115430000
Depreciation
-164000
Change In Working Capital
-23379000
Cash From Operations
-70535000
Capital Expenditures
131000
Cash From Investing
72429000
Cash From Financing
6278000
Net Change In Cash
8172000
PE
-
PB
14.640696126830115
ROE
-52.59897773542407
ROA
-11.003240351436773
FCF
-70666000
Fcf Percent
-1.5405375945586537
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
45871000
Quarters > 0 > income Statement > cost Of Revenue
6378000
Quarters > 0 > income Statement > gross Profit
39493000
Quarters > 0 > income Statement > operating Expenses
96919000
Quarters > 0 > income Statement > operating Income
-57426000
Quarters > 0 > income Statement > interest Expense
3014000
Quarters > 0 > income Statement > pretax Income
-60715000
Quarters > 0 > income Statement > net Income
-60715000
Quarters > 0 > income Statement > eps
-0.7009270916684953
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
86620992
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-57700000
Quarters > 0 > income Statement > operating Margin
-125.1902073205293
Quarters > 0 > income Statement > total Other Income Expense Net
-3289000
Quarters > 0 > balance Sheet > cash
116808000
Quarters > 0 > balance Sheet > short Term Investments
337366000
Quarters > 0 > balance Sheet > receivables
25403000
Quarters > 0 > balance Sheet > inventories
27505000
Quarters > 0 > balance Sheet > total Current Assets
529830000
Quarters > 0 > balance Sheet > property Plant Equipment
1599000
Quarters > 0 > balance Sheet > total Assets
551792000
Quarters > 0 > balance Sheet > payables
13826000
Quarters > 0 > balance Sheet > short Term Debt
23256000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
436362000
Quarters > 0 > balance Sheet > equity
115430000
Quarters > 0 > cash Flow > net Income
-60715000
Quarters > 0 > cash Flow > depreciation
-164000
Quarters > 0 > cash Flow > change In Working Capital
-23379000
Quarters > 0 > cash Flow > cash From Operations
-70535000
Quarters > 0 > cash Flow > capital Expenditures
131000
Quarters > 0 > cash Flow > cash From Investing
72429000
Quarters > 0 > cash Flow > cash From Financing
6278000
Quarters > 0 > cash Flow > net Change In Cash
8172000
Quarters > 0 > ratios > PE
-0.7009270916684953
Quarters > 0 > ratios > PB
14.640696126830115
Quarters > 0 > ratios > ROE
-52.59897773542407
Quarters > 0 > ratios > ROA
-11.003240351436773
Quarters > 0 > ratios > FCF
-70666000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.5405375945586537
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
37958000
Quarters > 1 > income Statement > cost Of Revenue
1279000
Quarters > 1 > income Statement > gross Profit
36679000
Quarters > 1 > income Statement > operating Expenses
106032000
Quarters > 1 > income Statement > operating Income
-69353000
Quarters > 1 > income Statement > interest Expense
7858000
Quarters > 1 > income Statement > pretax Income
-71847000
Quarters > 1 > income Statement > net Income
-71847000
Quarters > 1 > income Statement > eps
-0.8321670057613727
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
86337237
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-63989000
Quarters > 1 > income Statement > operating Margin
-182.70983718847148
Quarters > 1 > income Statement > total Other Income Expense Net
-2494000
Quarters > 1 > balance Sheet > cash
108636000
Quarters > 1 > balance Sheet > short Term Investments
360070000
Quarters > 1 > balance Sheet > receivables
37424000
Quarters > 1 > balance Sheet > inventories
17696000
Quarters > 1 > balance Sheet > total Current Assets
531676000
Quarters > 1 > balance Sheet > property Plant Equipment
1629000
Quarters > 1 > balance Sheet > total Assets
596149000
Quarters > 1 > balance Sheet > payables
17353000
Quarters > 1 > balance Sheet > short Term Debt
350000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
438725000
Quarters > 1 > balance Sheet > equity
157424000
Quarters > 1 > cash Flow > net Income
-71847000
Quarters > 1 > cash Flow > depreciation
55000
Quarters > 1 > cash Flow > change In Working Capital
-26751000
Quarters > 1 > cash Flow > cash From Operations
-87795000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
41887000
Quarters > 1 > cash Flow > cash From Financing
551000
Quarters > 1 > cash Flow > net Change In Cash
-45357000
Quarters > 1 > ratios > PE
-0.8321670057613727
Quarters > 1 > ratios > PB
10.700017112193821
Quarters > 1 > ratios > ROE
-45.63916556560626
Quarters > 1 > ratios > ROA
-12.051852808609928
Quarters > 1 > ratios > FCF
-87795000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.3129511565414407
Quarters > 1 > health Score
12
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
20042000
Quarters > 2 > income Statement > cost Of Revenue
885000
Quarters > 2 > income Statement > gross Profit
19157000
Quarters > 2 > income Statement > operating Expenses
102914000
Quarters > 2 > income Statement > operating Income
-83757000
Quarters > 2 > income Statement > interest Expense
8051000
Quarters > 2 > income Statement > pretax Income
-84846000
Quarters > 2 > income Statement > net Income
-84846000
Quarters > 2 > income Statement > eps
-0.9909369087384083
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
85622000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-83757000
Quarters > 2 > income Statement > operating Margin
-417.9073944716096
Quarters > 2 > income Statement > total Other Income Expense Net
-1089000
Quarters > 2 > balance Sheet > cash
153993000
Quarters > 2 > balance Sheet > short Term Investments
362320000
Quarters > 2 > balance Sheet > receivables
21482000
Quarters > 2 > balance Sheet > inventories
4664000
Quarters > 2 > balance Sheet > total Current Assets
548751000
Quarters > 2 > balance Sheet > property Plant Equipment
1801000
Quarters > 2 > balance Sheet > total Assets
640707000
Quarters > 2 > balance Sheet > payables
10047000
Quarters > 2 > balance Sheet > short Term Debt
384000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
425648000
Quarters > 2 > balance Sheet > equity
215059000
Quarters > 2 > cash Flow > net Income
-84846000
Quarters > 2 > cash Flow > depreciation
112000
Quarters > 2 > cash Flow > change In Working Capital
-17430000
Quarters > 2 > cash Flow > cash From Operations
-95162000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
94142000
Quarters > 2 > cash Flow > cash From Financing
930000
Quarters > 2 > cash Flow > net Change In Cash
-90000
Quarters > 2 > ratios > PE
-0.9909369087384083
Quarters > 2 > ratios > PB
7.767567132740318
Quarters > 2 > ratios > ROE
-39.452429333345734
Quarters > 2 > ratios > ROA
-13.242558611034372
Quarters > 2 > ratios > FCF
-95162000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-4.748128929248578
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7680000
Quarters > 3 > income Statement > cost Of Revenue
826000
Quarters > 3 > income Statement > gross Profit
7680000
Quarters > 3 > income Statement > operating Expenses
104045000
Quarters > 3 > income Statement > operating Income
-96365000
Quarters > 3 > income Statement > interest Expense
4806000
Quarters > 3 > income Statement > pretax Income
-94169000
Quarters > 3 > income Statement > net Income
-94169000
Quarters > 3 > income Statement > eps
-1.0976533979628074
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
85791198
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-89363000
Quarters > 3 > income Statement > operating Margin
-1254.7526041666665
Quarters > 3 > income Statement > total Other Income Expense Net
2196000
Quarters > 3 > balance Sheet > cash
154083000
Quarters > 3 > balance Sheet > short Term Investments
428830000
Quarters > 3 > balance Sheet > receivables
13871000
Quarters > 3 > balance Sheet > inventories
366000
Quarters > 3 > balance Sheet > total Current Assets
603057000
Quarters > 3 > balance Sheet > property Plant Equipment
2022000
Quarters > 3 > balance Sheet > total Assets
724816000
Quarters > 3 > balance Sheet > payables
11626000
Quarters > 3 > balance Sheet > short Term Debt
12596000
Quarters > 3 > balance Sheet > long Term Debt
331565000
Quarters > 3 > balance Sheet > total Liabilities
436692000
Quarters > 3 > balance Sheet > equity
288124000
Quarters > 3 > cash Flow > net Income
-94169000
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
27186000
Quarters > 3 > cash Flow > cash From Operations
-57388000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-268973000
Quarters > 3 > cash Flow > cash From Financing
347425000
Quarters > 3 > cash Flow > net Change In Cash
21064000
Quarters > 3 > ratios > PE
-1.0976533979628074
Quarters > 3 > ratios > PB
5.8092566845524845
Quarters > 3 > ratios > ROE
-32.68349738307118
Quarters > 3 > ratios > ROA
-12.992124897905125
Quarters > 3 > ratios > FCF
-57388000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.472395833333334
Quarters > 3 > health Score
20
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
23680000
Annuals > 0 > income Statement > cost Of Revenue
826000
Annuals > 0 > income Statement > gross Profit
22854000
Annuals > 0 > income Statement > operating Expenses
362526000
Annuals > 0 > income Statement > operating Income
-339672000
Annuals > 0 > income Statement > interest Expense
4929000
Annuals > 0 > income Statement > pretax Income
-318758000
Annuals > 0 > income Statement > net Income
-318758000
Annuals > 0 > income Statement > eps
-3.7228516035598327
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
85622000
Annuals > 0 > income Statement > income Tax Expense
-318758000
Annuals > 0 > income Statement > EBITDA
-313821000
Annuals > 0 > income Statement > operating Margin
-1434.4256756756756
Annuals > 0 > income Statement > total Other Income Expense Net
20914000
Annuals > 0 > balance Sheet > cash
154083000
Annuals > 0 > balance Sheet > short Term Investments
428830000
Annuals > 0 > balance Sheet > receivables
13871000
Annuals > 0 > balance Sheet > inventories
366000
Annuals > 0 > balance Sheet > total Current Assets
603057000
Annuals > 0 > balance Sheet > property Plant Equipment
2022000
Annuals > 0 > balance Sheet > total Assets
724816000
Annuals > 0 > balance Sheet > payables
11626000
Annuals > 0 > balance Sheet > short Term Debt
12596000
Annuals > 0 > balance Sheet > long Term Debt
331565000
Annuals > 0 > balance Sheet > total Liabilities
436692000
Annuals > 0 > balance Sheet > equity
288124000
Annuals > 0 > cash Flow > net Income
-318758000
Annuals > 0 > cash Flow > depreciation
8000
Annuals > 0 > cash Flow > change In Working Capital
13270000
Annuals > 0 > cash Flow > cash From Operations
-274903000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-219775000
Annuals > 0 > cash Flow > cash From Financing
353367000
Annuals > 0 > cash Flow > net Change In Cash
-141311000
Annuals > 0 > ratios > PE
-3.7228516035598327
Annuals > 0 > ratios > PB
5.857233760464244
Annuals > 0 > ratios > ROE
-110.6322277908123
Annuals > 0 > ratios > ROA
-43.97778194741838
Annuals > 0 > ratios > FCF
-274903000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-11.609079391891893
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
12000
Annuals > 1 > income Statement > gross Profit
-12000
Annuals > 1 > income Statement > operating Expenses
229954000
Annuals > 1 > income Statement > operating Income
-229954000
Annuals > 1 > income Statement > interest Expense
208000
Annuals > 1 > income Statement > pretax Income
-209360000
Annuals > 1 > income Statement > net Income
-209360000
Annuals > 1 > income Statement > eps
-2.9751095057292387
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
70370519
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-209140000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
20594000
Annuals > 1 > balance Sheet > cash
295394000
Annuals > 1 > balance Sheet > short Term Investments
282189000
Annuals > 1 > balance Sheet > receivables
1227000
Annuals > 1 > balance Sheet > inventories
2003000
Annuals > 1 > balance Sheet > total Current Assets
580876000
Annuals > 1 > balance Sheet > property Plant Equipment
1495000
Annuals > 1 > balance Sheet > total Assets
612880000
Annuals > 1 > balance Sheet > payables
9961000
Annuals > 1 > balance Sheet > short Term Debt
1047000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
58684000
Annuals > 1 > balance Sheet > equity
554196000
Annuals > 1 > cash Flow > net Income
-209360000
Annuals > 1 > cash Flow > depreciation
12000
Annuals > 1 > cash Flow > change In Working Capital
31860000
Annuals > 1 > cash Flow > cash From Operations
-160601000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
117609000
Annuals > 1 > cash Flow > cash From Financing
264132000
Annuals > 1 > cash Flow > net Change In Cash
221140000
Annuals > 1 > ratios > PE
-2.9751095057292387
Annuals > 1 > ratios > PB
2.5027299538250007
Annuals > 1 > ratios > ROE
-37.77724848248634
Annuals > 1 > ratios > ROA
-34.160031327502935
Annuals > 1 > ratios > FCF
-160601000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
126576000
Annuals > 2 > income Statement > cost Of Revenue
454000
Annuals > 2 > income Statement > gross Profit
-454000
Annuals > 2 > income Statement > operating Expenses
151757000
Annuals > 2 > income Statement > operating Income
-151757000
Annuals > 2 > income Statement > interest Expense
3137000
Annuals > 2 > income Statement > pretax Income
-149338000
Annuals > 2 > income Statement > net Income
-143749000
Annuals > 2 > income Statement > eps
-2.3658139659734503
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
60760906
Annuals > 2 > income Statement > income Tax Expense
-5589000
Annuals > 2 > income Statement > EBITDA
-151724000
Annuals > 2 > income Statement > operating Margin
-119.89397674124635
Annuals > 2 > income Statement > total Other Income Expense Net
2419000
Annuals > 2 > balance Sheet > cash
74356000
Annuals > 2 > balance Sheet > short Term Investments
410041000
Annuals > 2 > balance Sheet > receivables
4057000
Annuals > 2 > balance Sheet > inventories
-4251000
Annuals > 2 > balance Sheet > total Current Assets
489786000
Annuals > 2 > balance Sheet > property Plant Equipment
1059000
Annuals > 2 > balance Sheet > total Assets
497236000
Annuals > 2 > balance Sheet > payables
4350000
Annuals > 2 > balance Sheet > short Term Debt
439000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
29787000
Annuals > 2 > balance Sheet > equity
467449000
Annuals > 2 > cash Flow > net Income
-149338000
Annuals > 2 > cash Flow > depreciation
33000
Annuals > 2 > cash Flow > change In Working Capital
1656000
Annuals > 2 > cash Flow > cash From Operations
-133675000
Annuals > 2 > cash Flow > capital Expenditures
225000
Annuals > 2 > cash Flow > cash From Investing
-186188000
Annuals > 2 > cash Flow > cash From Financing
172254000
Annuals > 2 > cash Flow > net Change In Cash
-147609000
Annuals > 2 > ratios > PE
-2.3658139659734503
Annuals > 2 > ratios > PB
2.5619852802337797
Annuals > 2 > ratios > ROE
-30.751803940108974
Annuals > 2 > ratios > ROA
-28.90961233699893
Annuals > 2 > ratios > FCF
-133900000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.0578624699785109
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
139709000
Annuals > 3 > income Statement > cost Of Revenue
456000
Annuals > 3 > income Statement > gross Profit
139709000
Annuals > 3 > income Statement > operating Expenses
113489000
Annuals > 3 > income Statement > operating Income
26220000
Annuals > 3 > income Statement > interest Expense
1899000
Annuals > 3 > income Statement > pretax Income
24926000
Annuals > 3 > income Statement > net Income
24926000
Annuals > 3 > income Statement > eps
0.4787494754854474
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
52064809
Annuals > 3 > income Statement > income Tax Expense
-43000
Annuals > 3 > income Statement > EBITDA
26263000
Annuals > 3 > income Statement > operating Margin
18.76758118660931
Annuals > 3 > income Statement > total Other Income Expense Net
-1294000
Annuals > 3 > balance Sheet > cash
221965000
Annuals > 3 > balance Sheet > short Term Investments
224865000
Annuals > 3 > balance Sheet > receivables
429000
Annuals > 3 > balance Sheet > inventories
7651000
Annuals > 3 > balance Sheet > total Current Assets
448396000
Annuals > 3 > balance Sheet > property Plant Equipment
1261000
Annuals > 3 > balance Sheet > total Assets
449657000
Annuals > 3 > balance Sheet > payables
5669000
Annuals > 3 > balance Sheet > short Term Debt
362000
Annuals > 3 > balance Sheet > long Term Debt
19894664
Annuals > 3 > balance Sheet > total Liabilities
41289000
Annuals > 3 > balance Sheet > equity
408368000
Annuals > 3 > cash Flow > net Income
24926000
Annuals > 3 > cash Flow > depreciation
43000
Annuals > 3 > cash Flow > change In Working Capital
-9597000
Annuals > 3 > cash Flow > cash From Operations
29131000
Annuals > 3 > cash Flow > capital Expenditures
129000
Annuals > 3 > cash Flow > cash From Investing
-40873000
Annuals > 3 > cash Flow > cash From Financing
118464000
Annuals > 3 > cash Flow > net Change In Cash
106722000
Annuals > 3 > ratios > PE
0.4787494754854474
Annuals > 3 > ratios > PB
2.5129231119725346
Annuals > 3 > ratios > ROE
6.103808329741802
Annuals > 3 > ratios > ROA
5.5433363652739756
Annuals > 3 > ratios > FCF
29002000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.20758863065371594
Annuals > 3 > health Score
80
Valuation > metrics > PE
-0.7009270916684953
Valuation > metrics > PB
14.640696126830115
Valuation > final Score
20
Valuation > verdict
388.0% Overvalued
Profitability > metrics > ROE
-52.59897773542407
Profitability > metrics > ROA
-11.459336013438273
Profitability > metrics > Net Margin
-1.3236031479584052
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.7803170752837216
Risk > metrics > Interest Coverage
-19.053085600530856
Risk > final Score
-70
Risk > verdict
High
Liquidity > metrics > Current Ratio
14.288064289951999
Liquidity > metrics > Quick Ratio
13.54632975567661
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
21.907433154475154
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-17
Prev Risks > 1
-12
Prev Risks > 2
-50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-10T22:53:37.569Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-09
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.5536
Earnings History > 0 > eps Difference
0.5536
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.7
Earnings History > 1 > eps Estimate
-0.73
Earnings History > 1 > eps Difference
0.03
Earnings History > 1 > surprise Percent
4.1096
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-04
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.83
Earnings History > 2 > eps Estimate
-1.01
Earnings History > 2 > eps Difference
0.18
Earnings History > 2 > surprise Percent
17.8218
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.9846
Earnings History > 3 > eps Estimate
-1.2734
Earnings History > 3 > eps Difference
0.2888
Earnings History > 3 > surprise Percent
22.6794
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.1
Earnings History > 4 > eps Estimate
-0.2289
Earnings History > 4 > eps Difference
-0.8711
Earnings History > 4 > surprise Percent
-380.5592
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.98
Earnings History > 5 > eps Estimate
-1.11
Earnings History > 5 > eps Difference
0.13
Earnings History > 5 > surprise Percent
11.7117
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-01
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.8
Earnings History > 6 > eps Estimate
-0.91
Earnings History > 6 > eps Difference
0.11
Earnings History > 6 > surprise Percent
12.0879
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.85
Earnings History > 7 > eps Estimate
-0.98
Earnings History > 7 > eps Difference
0.13
Earnings History > 7 > surprise Percent
13.2653
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1
Earnings History > 8 > eps Estimate
-0.99
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-1.0101
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.73
Earnings History > 9 > eps Estimate
-0.8
Earnings History > 9 > eps Difference
0.07
Earnings History > 9 > surprise Percent
8.75
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.64
Earnings History > 10 > eps Estimate
-0.73
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
12.3288
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.59
Earnings History > 11 > eps Estimate
-0.6
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
1.6667
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-28
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.62
Earnings History > 12 > eps Estimate
-0.65
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
4.6154
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-03
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.58
Earnings History > 13 > eps Estimate
-0.63
Earnings History > 13 > eps Difference
0.05
Earnings History > 13 > surprise Percent
7.9365
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.62
Earnings History > 14 > eps Estimate
-0.64
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
3.125
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.63
Earnings History > 15 > eps Estimate
-0.63
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-01
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
1.81
Earnings History > 16 > eps Estimate
0.28
Earnings History > 16 > eps Difference
1.53
Earnings History > 16 > surprise Percent
546.4286
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.4
Earnings History > 17 > eps Estimate
-0.23
Earnings History > 17 > eps Difference
-0.17
Earnings History > 17 > surprise Percent
-73.913
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.44
Earnings History > 18 > eps Estimate
-0.71
Earnings History > 18 > eps Difference
0.27
Earnings History > 18 > surprise Percent
38.0282
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.54
Earnings History > 19 > eps Estimate
-0.65
Earnings History > 19 > eps Difference
0.11
Earnings History > 19 > surprise Percent
16.9231
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-08
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.44
Earnings History > 20 > eps Estimate
-0.49
Earnings History > 20 > eps Difference
0.05
Earnings History > 20 > surprise Percent
10.2041
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-02
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.46
Earnings History > 21 > eps Estimate
-0.44
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-4.5455
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.42
Earnings History > 22 > eps Estimate
-0.45
Earnings History > 22 > eps Difference
0.03
Earnings History > 22 > surprise Percent
6.6667
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-07
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.56
Earnings History > 23 > eps Estimate
-0.51
Earnings History > 23 > eps Difference
-0.05
Earnings History > 23 > surprise Percent
-9.8039
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-03
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.44
Earnings History > 24 > eps Estimate
-0.43
Earnings History > 24 > eps Difference
-0.01
Earnings History > 24 > surprise Percent
-2.3256
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-07
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.41
Earnings History > 25 > eps Estimate
-0.47
Earnings History > 25 > eps Difference
0.06
Earnings History > 25 > surprise Percent
12.766
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-07
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.47
Earnings History > 26 > eps Estimate
-0.43
Earnings History > 26 > eps Difference
-0.04
Earnings History > 26 > surprise Percent
-9.3023
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-06
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.53
Earnings History > 27 > eps Estimate
-0.56
Earnings History > 27 > eps Difference
0.03
Earnings History > 27 > surprise Percent
5.3571
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-07
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.7
Earnings History > 28 > eps Estimate
-0.67
Earnings History > 28 > eps Difference
-0.03
Earnings History > 28 > surprise Percent
-4.4776
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-05
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.68
Earnings History > 29 > eps Estimate
-0.76
Earnings History > 29 > eps Difference
0.08
Earnings History > 29 > surprise Percent
10.5263
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-07
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.74
Earnings History > 30 > eps Estimate
-0.87
Earnings History > 30 > eps Difference
0.13
Earnings History > 30 > surprise Percent
14.9425
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-08
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.79
Earnings History > 31 > eps Estimate
-0.96
Earnings History > 31 > eps Difference
0.17
Earnings History > 31 > surprise Percent
17.7083
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-05
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.8
Earnings History > 32 > eps Estimate
-0.78
Earnings History > 32 > eps Difference
-0.02
Earnings History > 32 > surprise Percent
-2.5641
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-07
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.68
Earnings History > 33 > eps Estimate
-0.8
Earnings History > 33 > eps Difference
0.12
Earnings History > 33 > surprise Percent
15
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-10
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.7
Earnings History > 34 > eps Estimate
-0.83
Earnings History > 34 > eps Difference
0.13
Earnings History > 34 > surprise Percent
15.6627
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-08
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.71
Earnings History > 35 > eps Estimate
-0.7
Earnings History > 35 > eps Difference
-0.01
Earnings History > 35 > surprise Percent
-1.4286
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-02
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.59
Earnings History > 36 > eps Estimate
-0.73
Earnings History > 36 > eps Difference
0.14
Earnings History > 36 > surprise Percent
19.1781
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-10
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.84
Earnings History > 37 > eps Estimate
-0.76
Earnings History > 37 > eps Difference
-0.08
Earnings History > 37 > surprise Percent
-10.5263
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-09
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
BeforeMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.47
Earnings History > 38 > eps Estimate
-0.53
Earnings History > 38 > eps Difference
0.06
Earnings History > 38 > surprise Percent
11.3208
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-16
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
AfterMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-2.85
Earnings History > 39 > eps Estimate
-0.48
Earnings History > 39 > eps Difference
-2.37
Earnings History > 39 > surprise Percent
-493.75
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASyndax Pharmaceuticals (NASDAQ:SNDX) Given "Buy" Rating at BTIG Research MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$39.3077
Analyst Picks
Strong Buy
9
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 98.34% of the total shares of Syndax Pharmaceuticals Inc
1.
BlackRock Inc(12.1392%)
since
2025/06/30
2.
Kynam Capital Management, LP(9.8907%)
since
2025/06/30
3.
Goldman Sachs Group Inc(6.7298%)
since
2025/06/30
4.
Vanguard Group Inc(5.8438%)
since
2025/06/30
5.
Eversept Partners, LLC(4.7194%)
since
2025/06/30
6.
Bank of America Corp(4.4565%)
since
2025/06/30
7.
State Street Corp(3.9966%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.9743%)
since
2025/07/31
9.
StemPoint Capital LP(2.7543%)
since
2025/06/30
10.
Franklin Resources Inc(2.7393%)
since
2025/06/30
11.
Point72 Asset Management, L.P.(2.4697%)
since
2025/06/30
12.
Catalio Capital Management, LP(2.4431%)
since
2025/06/30
13.
Kingdon Capital Management LLC(2.4378%)
since
2025/06/30
14.
iShares Russell 2000 ETF(2.3892%)
since
2025/08/31
15.
Geode Capital Management, LLC(2.379%)
since
2025/06/30
16.
Assenagon Asset Management SA(2.3682%)
since
2025/06/30
17.
Woodline Partners LP(2.1972%)
since
2025/06/30
18.
Qube Research & Technologies(1.9339%)
since
2025/06/30
19.
Millennium Management LLC(1.8558%)
since
2025/06/30
20.
Sphera Funds Management Ltd.(1.8244%)
since
2025/06/30
21.
SPDR® S&P Biotech ETF(1.7827%)
since
2025/08/31
22.
Sofinnova Ventures(1.7697%)
since
2025/06/30
23.
BNP Paribas Investment Partners SA(1.678%)
since
2025/06/30
24.
Eventide Healthcare & Life Sciences I(1.6416%)
since
2025/06/30
25.
Franklin Biotechnology Discv A(acc)USD(1.1811%)
since
2025/08/31
26.
Vanguard Institutional Extnd Mkt Idx Tr(1.0864%)
since
2025/07/31
27.
Belfius Equities Cure C Cap(1.0742%)
since
2025/08/31
28.
Fidelity Small Cap Index(0.9922%)
since
2025/06/30
29.
BNP Paribas Health Cr Innovtr Cl Cap(0.9662%)
since
2025/07/31
30.
BlackRock Advantage Small Cap Core Instl(0.9013%)
since
2025/07/31
31.
Franklin US Small Cap Growth Equity(0.8813%)
since
2025/06/30
32.
Franklin Small Cap Growth Adv(0.8097%)
since
2025/07/31
33.
iShares Russell 2000 Growth ETF(0.8018%)
since
2025/08/31
34.
BNP Paribas US Small Cap ClassicC(0.7151%)
since
2025/07/31
35.
Rhenman Healthcare Equity L/S RC2 SEK(0.6663%)
since
2025/05/31
36.
Franklin Biotechnology Discovery A(0.6402%)
since
2025/07/31
37.
Invesco MSCI World ETF(0.6203%)
since
2025/07/31
38.
iShares Biotechnology ETF(0.5731%)
since
2025/08/31
39.
Fidelity Extended Market Index(0.5382%)
since
2025/07/31
40.
Schwab US Small-Cap ETFâ„¢(0.4768%)
since
2025/08/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.5536
Date
2025-09-30
EPS Actual
-0.7
EPS Estimate
-0.73
EPS Difference
0.03
Surprise Percent
4.1096%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.